Lv5
1270 积分 2023-11-16 加入
Iptacopan in IgA Nephropathy — Final 24-Month Data
14天前
已完结
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
28天前
已完结
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
29天前
已完结
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
1个月前
已完结
Ivabradine and outcomes in chronic heart failure (SHIFT):a randomised placebo-controlled study
1个月前
已完结
Surrogate markers of clinical endpoints in clinical trials of heart failure
1个月前
已完结
Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction
1个月前
已完结
Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other Countries
1个月前
已完结
The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN)
1个月前
已完结
Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials
1个月前
已完结
皖公网安备34019202002308
